Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The timeline below maps key research and regulatory milestones that shaped modern GLP-1 treatment options
Where available, point-of-care gastric ultrasound can check whether the stomach is empty and help guide the plan
In the SURPASS program for type 2 diabetes, tirzepatide demonstrated A1C reductions of 2.07-2.59% across doses, with up to 97% of participants achieving A1C below 7.0%
During the same timeframe the share of Ozempic users who were overweight but did not have diabetes increased by 225%.2 The public perception of Ozempic as a magic weight loss cure is responsible for this increase, and is both untenably expensive, and medically inaccurate
New discoveries for an old drug: a review of recent olanzapine research
Whilst gastrointestinal side effects such as nausea and diarrhoea are well-documented, some patients report concerns about swollen lymph nodes during treatment
